Cautionary Statements

This Form 10-Q contains financial projections and other "forward-looking statements," as that term is used in federal securities laws, about Grapefruit's financial condition, results of operations and business. These statements include, among others, statements concerning the potential for revenues and expenses and other matters that are not historical facts. These statements may be made expressly in this Form 10-K. You can find many of these statements by looking for words such as "believes," "expects," "anticipates," "estimates," or similar expressions used in this Form 10-K. These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied by us in those statements. The most important facts that could prevent us from achieving our stated goals include, but are not limited to, the following:





  (a) volatility or decline of our stock price;

  (b) potential fluctuation in quarterly results;

  (c) our failure to earn revenues or profits;

  (d) inadequate capital to continue the business and barriers to raising the
      additional capital or to obtaining the financing needed to implement our
      business plans;

  (e) failure to make sales;

  (f) changes in demand for our products and services;

  (g) rapid and significant changes in markets;

  (h) litigation with or legal claims and allegations by outside parties, causing
      us to incur substantial losses and expenses;

  (i) insufficient revenues to cover operating costs;

  (j) dilution in the ownership of the Company through the issuance by us of
      additional securities and the conversion of outstanding warrants, notes and
      other securities;




24

We cannot assure that we will be profitable. We may not be able to develop, manage or market our products and services successfully. We may not be able to attract or retain qualified executives and technology personnel. We may not be able to obtain customers for our products or services. Our products and services may become obsolete. Government regulation may hinder our business. Additional dilution in outstanding stock ownership will be incurred due to the issuance or exercise of more shares, warrants and other convertible securities.

Because the statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. We caution you not to place undue reliance on the statements, which speak only as of the date of this Form 10-Q. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may make. We do not undertake any obligation to review or confirm analysts' expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this Form 10-Q or to reflect the occurrence of unanticipated events.

The following discussion should be read in conjunction with our financial statements and notes to those statements. In addition to historical information, the following discussion and other parts of this annual report contain forward-looking information that involves risks and uncertainties.

Results of Operations for the Three Months Ended September 30, 2022 as compared to the Three Months Ended September 30, 2021.





                                                   Three months ended      Three months ended
                                                   September 30, 2022      September 30, 2021
Net revenues                                       $             2,962     $           153,476
Cost of goods sold                                              62,758                 346,073
Gross income (loss)                                            (59,796 )              (192,597 )
Sales expense                                                    1,172                   3,800
Stock based compensation                                       106,011                  25,980
Stock option expenses                                            6,008                  32,877
General and administrative expense                             229,643                 352,462
Loss from operations                                          (402,630 )              (607,716 )
Change in value of derivatives                                  14,187                  13,877
Interest and other expense                                    (369,763 )              (388,273 )
Net loss before income taxes                                  (758,207 )              (982,112 )
Tax provision                                                        -                       -
Net loss                                                      (758,207 )              (982,112 )
Loss attributable to noncontrolling interest                         -                    (270 )

Net loss attributable to Grapefruit USA, Inc. $ (758,207 ) $ (981,842 )

The following sets forth selected items from our statements of operations for three months ended September 30, 2022 and for the three months ended September 30, 2021.

Revenue for the three months ended September 30, 2022 was $2,962 compared to $153,476 for the corresponding period in 2021, a decrease of $150,514 or 98.1%. The decrease was primarily due to the decline of our distribution business caused by a combination of decreased demand for and an over-supply of cannabis flowers in California. As a result of these market forces beyond our control we have severely limited our distribution operations and commenced the process of transitioning into a canna-biotech firm focusing on further developing and marketing of cannabis products based on our patented Hourglass Technology. On March 21, 2022, we received approval of our NNCP from Health Canada (NNCP ID No. NP-V2EHUWO907) which authorizes us to manufacture and sell our Hourglass™ products throughout Canada. As the Company expands marketing efforts, we anticipate to see additional growth.





25





Cost of goods sold for the three months ended September 30, 2022 was $62,758 as compared to $346,073 for the corresponding period in 2021, a decrease of $283,315, or 81.9%. Included in cost of goods sold are plant operation and other direct overhead expenses incurred to maintain our production facilities. These fixed carrying costs affect our gross margin more significantly at lower revenues than at our anticipated full operating activity levels. When inspecting inventory this quarter, we found some inventory was damaged, which necessitated a $68,500 reduction in inventory. Most of the product was salvageable and will be ready for resale in November 2022.

Our resulting gross loss for the three months ended September 30, 2022 was $59,796 as compared with the gross loss of $192,597 for the corresponding period in 2021, a decrease of $132,801, or 69.0%. The decrease was a result of the general decrease in sales and the associated costs of goods sold.

Sales expense for the three months ended September 30, 2022 were $1,172 compared to $3,800 for 2021, decrease of $2,628, or 69.2%. Stock based compensation for the three months ended September 30, 2022 were $106,011 compared to $25,980 for 2021, an increase of $80,031, or 308%. Stock option expenses for the three months ended September 30, 2022 were $6,008 compared to $32,877 for 2021, a decrease of $26,869, or 81.7%. General and administrative expenses for the three months ended September 30, 2022 were $229,643 compared to $352,462 for 2021, a decrease of $122,819, or 34.8%.

Our resulting net loss from operations for the three months ended September 30, 2022 was $402,630 as compared to $607,716 for the corresponding period for 2021, a decrease of $205,086, or 33,7%. Change in value of derivatives gain for the three months ended September 30, 2022 was $14,187 as compared to $13,877 for 2021, a decrease of $310, or 2.2%. Interest and other expense for the three months ended September 30, 2022 was $369,763 as compared to $388,273 for 2021, a decrease of $18,510, or 4.8%.

Net loss for the three months ended September 30, 2022 was $758,207 as compared to $982,112 for the corresponding period for 2021, a decrease of $223,905, or 22.8%. Loss attributable to noncontrolling interest for the three months ended September 30, 2022 was $0 as compared to $270 the corresponding period for 2021, a decrease of $270. Our resulting net loss attributable to Grapefruit USA, Inc. and subsidiary for the three months ended September 30, 2022 was $758,207 as compared to $981,842 for the corresponding period for 2021, a decrease of $223,635, or 22.8%.

Results of Operations for the Nine Months Ended September 30, 2022 as compared to the Nine Months Ended September 30, 2021.





                                                    Nine months ended       Nine months ended
                                                   September 30, 2022      September 30, 2021
Net revenues                                       $            32,673     $           586,780
Cost of goods sold                                             297,069                 926,671
Gross income (loss)                                           (264,396 )              (339,891 )
Sales expense                                                    6,744                   5,760
Stock based compensation                                       301,916                 265,024
Stock option expenses                                           27,006                  65,754
General and administrative expense                             974,685               1,011,199
Loss from operations                                        (1,574,747 )            (1,687,628 )
Change in value of derivatives                                 138,081                  91,210
Interest and other expense                                  (1,171,036 )            (2,149,021 )
Net loss before income taxes                                (2,607,702 )            (3,745,439 )
Tax provision                                                        -                       -
Net loss                                                    (2,607,702 )            (3,745,439 )
Loss attributable to noncontrolling interest                         -                    (270 )

Net loss attributable to Grapefruit USA, Inc. $ (2,607,702 ) $ (3,745,169 )






26





The following sets forth selected items from our statements of operations for nine months ended September 30, 2022 and for the nine months ended September 30, 2021.

Revenue for the nine months ended September 30, 2022 was $32,673 compared to $586,780 for the corresponding period in 2021, a decrease of $554,107 or 94.4%. The decrease was primarily due to the decline of our distribution business caused by a combination of decreased demand for and an over-supply of cannabis flowers in California. As a result of these market forces beyond our control we have severely limited our distribution operations and commenced the process of transitioning into a canna-biotech firm focusing on further developing and marketing of cannabis products based on our patented Hourglass Technology. On March 21, 2022, we received approval of our NNCP from Health Canada (NNCP ID No. NP-V2EHUWO907), which authorizes us to manufacture and sell our Hourglass™ products throughout Canada. As the Company expands marketing efforts, we anticipate to see additional growth.

Cost of goods sold for the nine months ended September 30, 2022 was $297,069 as compared to $926,671 for the corresponding period in 2021, a decrease of $629,602, or 67.9%. Included in cost of goods sold are plant operation and other direct overhead expenses incurred to maintain our production facilities. These fixed carrying costs affect our gross margin more significantly at lower revenues than at our anticipated full operating activity levels. When inspecting inventory this quarter, we found some inventory was damaged, which necessitated a $68,500 reduction in inventory. Most of the product was salvageable and will be ready for resale in November 2022.

Our resulting gross loss for the nine months ended September 30, 2022 was $264,396 as compared with the gross loss of $339,891 for the corresponding period in 2021, a decrease of $75,495, or 22.2%. The decrease was a result of the general decrease in sales and the associated costs of goods sold.

Sales expense for the nine months ended September 30, 2022 was $6,744 compared to the $5,760 for 2021, an increase of $984, or 17.1%. Stock based compensation for the nine months ended September 30, 2022 were $301,916 compared to $265,024 for 2021, an increase of $36,892 or 13.9%. Stock option expenses for the nine months ended September 30, 2022 were $27,006 compared to $65,754 for 2021, a decrease of $38,748, or 58.9%. General and administrative expense for the nine months ended September 30, 2022 were $974,685 compared to $1,011,199 for 2021, a decrease of $36,514, or 3.6%.

Our resulting net loss from operations for the nine months ended September 30, 2022 was $1,574,747 as compared to $1,687,628 for the corresponding period for 2021, a decrease of $112,881, or 6.7%. Change in value of derivatives gain for the nine months ended September 30, 2022 was $138,081 as compared to $91,210 for 2021, an increase of $46,871, or 51.4%. Interest and other expense for the nine months ended September 30, 2022 was $1,171,036 as compared to $2,149,021 for 2021, a decrease of $977,985, or 45.5%.

Net loss for the nine months ended September 30, 2022 was $2,607,702 as compared to $3,745,439 for the corresponding period for 2021, a decrease of $1,137,737, or 30.4%. Loss attributable to noncontrolling interest for the nine months ended September 30, 2022 was $0 as compared to $270 for the corresponding period for 2021, a decrease of $270. Our resulting net loss attributable to Grapefruit USA, Inc. and subsidiary for the nine months ended September 30, 2022 was $2,607,702 as compared to $3,745,169 for the corresponding period for 2021, a decrease of $1,137,467, or 30.4%.

Liquidity and Capital Resources

Our cash position increased to $23,583 as of September 30, 2022 from $9,095 as of December 31, 2021. Our total current assets decreased to $644,496 as of September 30, 2021, from $714,199 as of December 31, 2021.

Our total current liabilities increased to $7,913,321 as of September 30, 2022 from $7,703,573 as of December 31, 2021.





27





During the nine months ended September 30, 2022, we used $317,552 of net cash for operating activities, as compared to cash used by operations of $998,581 used during the nine months ended September 30, 2021. Net cash used in investing activities during the nine months ended September 30, 2022 was $0, as compared to $62,250 during the nine months ended September 30, 2021. Net cash provided by financing activities during the nine months ended September 30, 2022 was $332,040, as compared to $798,253 during the nine months ended September 30, 2021.

We expect our working capital requirements in the next year to be met primarily by the proceeds of issuance of debt, equity and other securities to our existing creditors, shareholders, and other investors, as well as from cash flow from operations. We also expect that, as in the past, significant amounts of our convertible debt with a major lender will be converted into equity. We expect to need additional working capital from outside sources to cover our anticipated operating expenses. There is no assurance that the Company will be able to raise sufficient additional capital or financing to continue in business or to effectively execute its business plan.





COVID-19 Impact


The COVID-19 pandemic has had, and continues to have, a significant impact around the world, prompting governments and businesses to take unprecedented measures, such as restrictions on travel and business operations, temporary closures of businesses, and quarantine and shelter-in-place orders. The COVID-19 pandemic has at times significantly curtailed global economic activity and caused significant volatility and disruption in global financial markets. The COVID-19 pandemic and the measures taken by many countries in response have affected and could in the future materially impact the Company's business, results of operations and financial condition.

Certain of the Company's outsourcing partners, component suppliers and logistical service providers have experienced disruptions during the COVID-19 pandemic, resulting in supply shortages. Similar disruptions could occur in the future.





Going Concern Qualification



Our consolidated financial statements have been prepared on a going concern basis which assumes we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future. During the nine months ended September 30, 2022, we incurred a net loss of $2,607,703, had a working capital deficit of $7,268,825 and had an accumulated deficit of $19,433,867 at September 30, 2022. Our ability to continue as a going concern is dependent upon our ability to generate profitable operations in the future and or obtaining the necessary financing to meet our obligations and repay our liabilities arising from normal business operations as they come due. There is no assurance that these events will be satisfactorily completed. As a result, there is doubt about our ability to continue as a going concern for one year from the issuance date of these financial statements

Off-Balance Sheet Arrangements

None.

© Edgar Online, source Glimpses